Peregrine Capital Management’s MyoKardia, Inc. Common Stock MYOK Stock Holding History

Peregrine Capital Management’s Portfolio MYOK Stock Details MYOK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-118,802	Closed	-$16.2M	–	395
2020 Q3	$16.2M	Buy	+118,802	New	+$12.6M	0.43%	86

Peregrine Capital Management's MYOK Position: Q4 2020 in Review

Peregrine Capital Management sold out of MyoKardia, Inc. Common Stock (MYOK) in Q4 2020, closing a stake of 118,802 shares — an estimated $16.2M sold.

Peregrine Capital Management first reported a position in MYOK in Q3 2020 and held it in 1 quarter. The position peaked at $16.2M in Q3 2020. 0 funds tracked by Wall St. Rank hold MYOK as of Q4 2020.

Peregrine Capital Management reported no remaining MyoKardia, Inc. Common Stock position as of Q4 2020 after selling out during the quarter.
Peregrine Capital Management sold 118,802 MyoKardia, Inc. Common Stock shares in Q4 2020, an estimated $16.2M.
Peregrine Capital Management first reported a position in MyoKardia, Inc. Common Stock in Q3 2020 and held it in 1 quarter.
Peregrine Capital Management's MyoKardia, Inc. Common Stock position peaked at $16.2M in Q3 2020.
0 funds tracked by Wall St. Rank held MyoKardia, Inc. Common Stock as of Q4 2020.

Based on Peregrine Capital Management's 13F filing for Q4 2020, filed 19 Jan 2021.